Newcastle University will enter into a research agreement with Nordic Biosciences. The reason why this opportunity will not be advertised via Find a Tender and Contracts Finder is because Nordic Biosciences will measure a range of blood-based biomarkers in biological samples as part of a natural history study in subjects with liver disease, including biomarker assays that rely on access to Nordic Biosciences proprietary technologies that are not otherwise available. The use of a single laboratory analysis facility for these assays is essential for this work to ensure sample stability by minimising freeze/thaw cycles and to minimise sample wastage as biological sample volumes are limited. In addition, Nordic Biosciences will collaborate as required with the academic investigators to support the downstream analysis of data, sharing know-how of collagen biology.

You must be logged in to view the rest of this content, click here to login

Don't have an account, click to sign up for our 14-day free trial.